Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial.
Al Hadidi S, van Rhee F. Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial. J Clin Oncol. 2023 03 20; 41(9):1788.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Dexamethasone
Humans
Multiple Myeloma
Neoplasm Recurrence, Local
Survival Analysis
authors with profiles
Samer Al Hadidi
Frits Van Rhee
Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial.